By: P.T.,STA
Slovenia will not change its Covid-19 vaccination strategy for the time being, the head of the national immunisation advisory body has said after the European Medicines Agency (EMA) announced that unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine.
Speaking for the commercial broadcaster POP TV on Wednesday evening, Bojana Beović said Slovenia would not change its approach over the EMA announcement for the time being, which means the AstraZeneca vaccine remains reserved for 60- to 65-year-olds.
